HLS Therapeutics, Inc. (HLS.TO)
3.91
-0.08
(-2.00%)
CAD |
TSX |
Sep 18, 16:00
HLS Therapeutics Market Cap : 122.26M for Sept. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 122.26M |
| September 17, 2026 | 124.76M |
| September 16, 2026 | 126.02M |
| September 15, 2026 | 127.89M |
| September 14, 2026 | 129.77M |
| September 11, 2026 | 121.95M |
| September 10, 2026 | 116.63M |
| September 09, 2026 | 117.26M |
| September 08, 2026 | 118.20M |
| September 04, 2026 | 115.70M |
| September 03, 2026 | 112.57M |
| September 02, 2026 | 112.88M |
| September 01, 2026 | 117.26M |
| August 31, 2026 | 117.26M |
| August 28, 2026 | 118.51M |
| August 27, 2026 | 115.70M |
| August 26, 2026 | 114.13M |
| August 25, 2026 | 120.07M |
| August 24, 2026 | 115.38M |
| August 21, 2026 | 117.26M |
| August 20, 2026 | 123.20M |
| August 19, 2026 | 121.01M |
| August 18, 2026 | 121.95M |
| August 17, 2026 | 121.95M |
| August 14, 2026 | 121.95M |
| Date | Value |
|---|---|
| August 13, 2026 | 121.01M |
| August 12, 2026 | 124.45M |
| August 11, 2026 | 119.76M |
| August 10, 2026 | 122.58M |
| August 07, 2026 | 126.02M |
| August 06, 2026 | 125.09M |
| August 05, 2026 | 128.85M |
| August 04, 2026 | 128.85M |
| July 31, 2026 | 131.35M |
| July 30, 2026 | 131.35M |
| July 29, 2026 | 132.91M |
| July 28, 2026 | 131.66M |
| July 27, 2026 | 131.04M |
| July 24, 2026 | 128.53M |
| July 23, 2026 | 128.53M |
| July 21, 2026 | 131.35M |
| July 20, 2026 | 128.53M |
| July 17, 2026 | 128.53M |
| July 16, 2026 | 130.10M |
| July 15, 2026 | 131.35M |
| July 14, 2026 | 129.47M |
| July 13, 2026 | 132.29M |
| July 10, 2026 | 134.79M |
| July 09, 2026 | 133.85M |
| July 08, 2026 | 134.16M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Bausch Health Cos., Inc. | 2.961B |
| Cipher Pharmaceuticals, Inc. | 372.84M |
| BioSyent, Inc. | 178.38M |
| Revive Therapeutics Ltd. | 8.714M |
| Knight Therapeutics, Inc. | 1.007B |
Market Cap Related Metrics
| PS Ratio | 1.574 |
| Price to Book Value | 1.560 |
| Price to Free Cash Flow | 5.600 |
| Price | 3.91 |
| Earnings Yield | -9.65% |